• Articles
• Presentations
• Events/Seminars
• IP Alerts
• Q&A Booklets
• In the News
• Press Releases
• IP Case Law Analysis
• IP Outlook Newsletter
• RSS Feeds

Gilead's Hypertension Drug Darusentan Will Likely Receive Patent

Michael Siekman was quoted in Pharmawire.